Hokusai-VTE Study: Once-daily edoxaban matches warfarin for averting recurrent DVT, PE

The factor Xa inhibitor joins others in this new class of oral anticoagulants in rivaling the older agent for efficacy in acute VTE and outclassing it for safety in a major randomized trial.
Source: theHeart.org - Category: Cardiology Source Type: news